ELAN
Elanco Animal Health IncorporatedNYSEHealthcare$23.08-0.17%ClosedMarket Cap: $11.47B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.75
P/S
2.43
EV/EBITDA
20.70
DCF Value
$4.68
FCF Yield
2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
46.4%
Operating Margin
5.3%
Net Margin
-4.9%
ROE
-3.5%
ROA
-4.5%
ROIC
2.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.14B | 39.3% | $19.0M | $-276.0M | $-0.55 | — |
| FY 2025 | $4.71B | 43.5% | $252.0M | $-232.0M | $-0.47 | — |
| Q3 2025 | $1.14B | 53.4% | $27.0M | $-34.0M | $-0.07 | — |
| Q2 2025 | $1.24B | 46.5% | $85.0M | $11.0M | $0.02 | — |
| Q1 2025 | $1.19B | 46.6% | $121.0M | $67.0M | $0.13 | — |
| Q4 2024 | $1.02B | 38.1% | $8.0M | $-8.0M | $-0.02 | — |
| FY 2024 | $4.44B | 43.0% | $251.0M | $338.0M | $0.68 | — |
| Q3 2024 | $1.03B | 39.3% | $-5.0M | $364.0M | $0.73 | — |
| Q2 2024 | $1.18B | 47.1% | $115.0M | $-50.0M | $-0.10 | — |
| Q1 2024 | $1.21B | 46.2% | $133.0M | $32.0M | $0.06 | — |
| Q4 2023 | $1.03B | 36.8% | $10.0M | $-141.0M | $-0.29 | — |
| FY 2023 | $4.42B | 43.9% | $326.0M | $-1.23B | $-2.50 | — |